The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.

Taking drops of a medical dye is trending in wellness and biohacking circles. Some influencers claim it boosts longevity and ...

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...

A yearlong pattern of intense disruption followed by little improvement played out across nearly every major healthcare ...

Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S. regulatory decision ...

Sanofi’s experimental multiple sclerosis drug got hit with two setbacks on Monday: a regulatory delay in the US as well as a failure in a late-stage clinical trial.

Ascendis Pharma's Yorvipath and Skytrofa drove Q3 revenues to €213.6 million, nearly quadrupling year-over-year. Read why ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Doctors and dietitians explain how energy drinks affect your body, how much caffeine is safe, and why sugar and sweeteners ...

Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner Marty Makary accountable for leaving ...

The Philadelphia Phillies’ superstar might have risked "neurological complications” with an unapproved health procedure.

A total of 1,021 cases of the frozen original White Castle burgers — often found in your local grocery store or convenience ...